BioSpace News Archive

Business

HAP partners with Livongo to help Medicare Advantage members manage diabetes

Health Alliance Plan announced it has partnered with Livongo, a whole person platform that empowers people with chronic conditions to live better and healthier lives, to provide HAP Medicare Advantage members with a more personalized experience to help them better manage their diabetes.

April 16, 2019
·
4 min read
Business

Newly Released Data Indicates Certified PAs Poised to Meet Current and Future Health Care Demands

For the sixth consecutive year, the National Commission on Certification of Physician Assistants (NCCPA) has published the Statistical Report of Certified Physician Assistants, the most comprehensive report of PA data nationwide.

April 16, 2019
·
2 min read
Pharm Country

VISITOR Clinical Study Demonstrates Feasibility and Utility of Transparency Life Sciences’ New Virtual Trials Platform

Top-Line Results Show High Rates of Participant Compliance and Satisfaction and Excellent Data Integrity with Home-Based Clinical Data Capture Using Transparency Virtual TrialsTM (TVT) Platform

April 16, 2019
·
4 min read
Drug Development

Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program

Aims to augment current cancer therapies by altering patients’ gut microbiome to improve response

April 16, 2019
·
5 min read
Policy

NanoViricides Submits Pre-IND Briefing Documents to the US FDA

NanoViricides, Inc. a company with novel platform technology to meet unmet medical needs in treating difficult and life-threatening viral diseases, reports that it has submitted the required pre-IND Briefing Documents for its lead drug candidate NV-HHV-101 to the US FDA, ahead of schedule.

April 16, 2019
·
8 min read
Drug Development

Phase 2B GI Safety Results For ATB-346 Published in British Journal of Pharmacology

Antibe Therapeutics Inc. highlights that a research article has been published in the British Journal of Pharmacology on the successful Phase 2B GI safety trial for its lead drug, ATB-346.

April 16, 2019
·
3 min read
Business

Flagship Pioneering Unveils Kintai Therapeutics and Appoints Pharmaceutical Drug Developer Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer

Just two years since its founding by Flagship Labs, the company has elucidated a new understanding of the multimodal enteric system, translating this insight into 10+ therapeutic programs

April 16, 2019
·
8 min read
Business

KSQ Therapeutics Announces Appointment of Douglas Pagán as Chief Financial Officer

KSQ Therapeutics announced the appointment of Douglas Pagán as Chief Financial Officer.

April 16, 2019
·
3 min read
Business

Frank Malinoski, MD, PhD, joins Affinivax as Senior Vice President of Clinical Development and Regulatory Affairs

Industry veteran brings over 30 years of development and commercial experience across multiple vaccine and immunotherapy products

April 16, 2019
·
5 min read
Business

KSQ Therapeutics Announces Appointment of Beni B. Wolf, MD, PhD, as Chief Medical Officer

KSQ Therapeutics announced the appointment of Beni B. Wolf, MD, PhD, as Chief Medical Officer.

April 16, 2019
·
3 min read